CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dimension Therapeutics, Inc. (“Dimension” or the “Company”), a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, today announced the appointment of several senior executives to its management team. The addition of these newly created positions is intended to complement the continued growth of Dimension’s programs and pipeline as the Company prepares to launch its first clinical trial and advances additional programs toward the clinic.
Help employers find you! Check out all the jobs and post your resume.
